Chinese Biotech Start-Up BioHeng Raises $15M Series A Round


Nanjing-based biotechnology start-up BioHeng Biotech today announced that it has raised a RMB100 million (US$14.8 million) series A financing round from Decheng Capital, an early-stage life science-focused venture capital firm. Founded in 2017, BioHeng is a clinical biopharmaceutical and biotechnology firm engaged in novel immunotherapy and next-generation gene therapy development for treating cancers and various […]

Chinese Biotech Start-Up BioHeng Raises $15M Series A Round comes originally from China Money Network. All Rights Reserved.


Print Print | Email Email | Category: China News

Sorry, comments are closed at this time.